We are thrilled to announce that MEPSGEN has successfully raised $14.9 million in a recent funding round, signaling a significant milestone for the biotechnology company founded by Dr. YongTae Kim and the renowned Dr. Robert Langer in 2019. MEPSGEN is at the forefront of innovation, specializing in the development of human microphysiological systems and advanced microfluidic modules. These state-of-the-art technologies not only enable lab-scale nanoparticle synthesis but also facilitate the automated large-scale Good Manufacturing Practice (GMP) production of lipid nanoparticles encapsulating modern therapeutics, such as mRNAs and antisense oligonucleotides (ASOs). The funding will be pivotal in propelling the company's mission to revolutionize drug development, allowing for more efficient, precise, and scientifically robust processes that could significantly improve patient outcomes. With industry-leading expertise in nanotechnology, drug delivery, and tissue engineering, our team is committed to harnessing these advancements to push the boundaries of what’s possible in the medical field. The infusion of capital will enable us to expand our research and development capabilities, enhance our microphysiological systems, and scale our nanoparticle manufacturing efforts. This marks an exciting new chapter for MEPSGEN as we endeavor to transform the therapeutics landscape and contribute to the advancement of personalized medicine. We look forward to sharing more updates as we forge ahead on this groundbreaking journey.
MEPSGEN Secures $14.9 Million in Series C Funding to Revolutionize Drug Development with Innovative Technology
Recently funded · $14.9M Series cBiotechnology
Get the full MEPSGEN company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  SOLIVIS | Series c | $16.0M | 1d ago |
| 2 |  SKAN Switzerland | Series c | $63.0M | 1d ago |
| 3 |
